Literature DB >> 25288895

Distal Deletion of Chromosome 11q Encompassing Jacobsen Syndrome without Platelet Abnormality.

Frenny J Sheth1, Chaitanya Datar2, Joris Andrieux3, Anand Pandit4, Darshana Nayak5, Mizanur Rahman1, Jayesh J Sheth1.   

Abstract

Terminal 11q deletion, known as Jacobsen syndrome (JBS), is a rare genetic disorder associated with numerous dysmorphic features. We studied two cases with multiple congenital anomalies that were cytogenetically detected with deletions on 11q encompassing JBS region: 46,XX,der(11) del(11)(q24). Array comparative genomic hybridization (aCGH) analysis confirmed partial deletion of 11.8-11.9 Mb at 11q24.1q25 (case 1) and 13.9-14 Mb deletion at 11q23.3q25 together with 7.3-7.6 Mb duplication at 12q24.32q24.33 (case 2). Dysmorphism because of the partial duplication of 12q was not overtly decipherable over the Jacobsen phenotype except for a triangular facial profile. Aberrant chromosome 11 was inherited from phenotypically normal father, carrier of balanced translocation 46,XY,t(11;12)(q23.3; q24.32). In the present study, both cases had phenotypes that were milder than the ones described in literature despite having large deletion size. Most prominent features in classical JBS is thrombocytopenia, which was absent in both these cases. Therefore, detailed functional analysis of terminal 11q region is warranted to elucidate etiology of JBS and their clinical presentation.

Entities:  

Keywords:  11q deletion; Jacobsen syndrome; array-CGH; inheritance; milder phenotype; platelet abnormality

Year:  2014        PMID: 25288895      PMCID: PMC4179602          DOI: 10.4137/CMPed.S18121

Source DB:  PubMed          Journal:  Clin Med Insights Pediatr        ISSN: 1179-5565


Introduction

Terminal 11q deletion syndrome, also known as Jacobsen Syndrome (JBS), is a rare genetic disorder associated with multiple dysmorphic features and occurs in 1 in 100,000 live births with a female predominance of 2:1.1–4 JBS occurs because of the loss of contiguous set of genes present at 11q23 with deletion size varying from 7 to 20 Mb in size but could be as small as 2.9 Mb in some cases.1,3,5 A “de novo” deletion is seen in 85% JBS patients, and 15% cases arise as a result of parental translocations.6 Hallmark clinical features of JBS include pre- and post-natal physical growth retardation, intellectual disability, and characteristic facial dysmorphism. We present two cases of JBS who presented milder phenotypes than those described in literature despite of larger deletion size.

Case 1

A 4-year-old girl was born to non-consanguineous young parents. No family history of physical and intellectual disability was recorded. Antenatal period was uneventful except suspected intrauterine growth retardation. She was born through Caesarian section with a birth weight of 2.25 kg. She initially had developmental delay but by the age of referral (ie, 4 years), she achieved all motor milestones but was failing to thrive. Short stature and facial dysmorphism were also noted. Her height was 90 cm (microbrachycephaly. The facial profile showed sparse eyebrows, telecanthus, deep set eyes, strabismus, prominent epicanthal folds, low set dysmorphic ears, depressed nasal bridge, and a bulbous upturned nasal tip. The vermillion of upper lip was thin, and retrognathia along with a high arched palate is noted. No major limb dysmorphism was found except for bilateral short and clinodactyly. The neck was short, broad, and had slight webbing. No neurocutaneous markers were noted, and the genitalia was normal (Fig. 1a). Central nervous system examination revealed hypotonia. The child had no meaningful speech despite normal hearing potential, but her receptive language had developed marginally. The child had a low IQ of 30 suggesting severe intellectual disability. 2D echocardiogram showed ventricular septal defect and tricuspid valve tags. The skeletal survey and ultrasonography of the abdomen were normal. Magnetic resonance imaging revealed marginal white matter affection and a thin corpus callosum. Hearing and ophthalmic evaluation including fundus was normal. There were no symptoms of platelet dysfunction on clinical examination in the form of superficial bleeding (which may reflect qualitative and quantitative platelet abnormalities). The platelet count at presentation was normal. Platelet morphology with peripheral smear did not reveal giant platelets or any other abnormality. Karyotyping showed heterozygous segmental distal deletion of 11 with breakpoint at q24 region ie, 46,XX,der(11)del(11) (q24) of “de novo” origin. Oligonucelotide array comparative genomic hybridization [aCGH] characterized the large deletion of 11.8–11.9 Mb size at 11q24.1q25 [arr cgh 11q24.1q25 (123,045,174–134,868,407)x1 (hg19-GRCh37)] (Fig. 2a).
Figure 1

(A) Front and side views of case 1 at the age of 4 years. Note the short, broad, and webbing of the neck. (B) Anterior and posterior views of case 2 at the age of 6½ years portraying mild ptosis, strabismus, and lordosis.

Figure 2

(A) aCGH study shows 11.8–11.9 Mb deletion at 11q24.1q25 of encompassing JBS ie, arr 11q24.1q25(123,045,174–134,868,407)x1(hg19-GRCh37). (B) aCGH showed a 13.9–14 Mb deletion at 11q23.3q25 together with 7.3–7.6 Mb duplication at 12q24.32q24.33 ie, 46,XX,der(11)del(11)(q24), arr 11q23.3q25(121,000,318–134,868,407)x1, and 12q24.32q24.33(126,482,698–133,767,986)x3(hg19-GRCh37).

Case 2

A girl was referred at an age of 6½ years for chromosomal analysis because of multiple congenital anomalies and developmental delay. She was born to young and non-consanguineous parents. The birth history was uneventful. She presented a global developmental delay during examination. At the time of the referral, her height was 107 cm (at the third centile). Physical examination showed microcephaly, flat occiput, epicanthal folds, hypertelorism, mild ptosis, strabismus, low and posteriorly set ears, depressed and low nasal bridge, prominent and bulbous nasal tip, choanal atresia, flat alae nasi, smooth and long philtrum, large open mouth, thin vermillion of upper lip, everted lower lip, retrognathia, and high arched palate. Her neck was short and broad. Arachnodactyly was noted in the upper limb. She had no genital abnormalities (Fig. 1b). Her cardiac evaluations and ultrasound of the abdomen were unremarkable, and skeletal survey showed mild lordosis. She had an affected cognition with an IQ of 37, but did have some meaningful words to her vocabulary. Iron deficiency anemia was detected on the hemogram and later on confirmed by serum iron profiles. The patient neither had abnormal bleeding time nor bleeding manifestation. There was no thrombocytopenia as evident by normal platelet count or platelet dysfunction as evidenced by the clinical examination and platelet morphology on smear examination. Cytogenetic study exhibited heterozygous deletion of the #11q distal region at the site q24 ie, 46,XX,der(11)del(11)(q24). Oligonucleotide aCGH further confirmed a 13.9–14 Mb deletion at 11q23.3q25, but a relatively large 7.3–7.6 Mb duplication at 12q24.32q24.33 was also observed [arr cgh 11q23.3q25(121,000,318–134,868,407)x1, 12q24.32q24.33(126,482,69 8–133,767,986)x3 (hg19-GRCh37)] (Fig. 2b). This structural rearrangement was missed by the conventional cytogenetic analysis. The aberrant chromosome 11 was inherited from the phenotypically normal father who was the carrier of a balanced translocation 46,XY,t(11;12)(q23.3; q24.32).

Discussion

JBS is a rare chromosomal disorder involving terminal deletion of chromosome 11q. The implementation of array technology in the clinics has permitted precise characterization of the deletions and detailed genotype–phenotype correlation in cases with JBS. We present two cases of JBS with deletions spanning 11.9 and 14 Mb, respectively. Despite the difference in the deletion size, both patients had nearly similar phenotypes as shown in Table 1. The critical region underlying intellectual disability7,8 is located within the 4.11 Mb of the 11q telomere encompassing genes SNX19, THYN1, OPCML, VPS26B, NCAPD3, and NTM, which were deleted in our patients. Deletion of the NTM (neurotrimin) gene hampers the normal expression of the NTM protein in the developing nervous system that may promote neurite outgrowth that has been associated with cognitive function.7,8 Larger deletion encompassing all four genes associated with JBS-related thrombocytopenia (FLI1, ETS1, NFRKB, and JAM3) did not manifest a phenotype in both of our patients. Thrombocytopenia is a usual feature in >88% JBS patients.9 We could not see any correlation between the size of deletion and manifestation of thrombocytopenia; this could be because of the heterogeneous nature of the deletion. Recently, it has been shown that second hit may be a prerequisite for the full blown expression of the thrombocytopenia.10 JAM3 is suggested as the candidate gene for JBS cardiac phenotype11 that was deleted in both these patients. However, ventricular septal defect and tricuspid valve tags were observed only in case 1. Absence of heart disease in case 2 even with ETS1 deletion is consistent with the hypothesis of a more centromeric localization of the cardiac critical region.12,13 A crucial role of the ETS1 gene in heart development is reported.13 ETS1 gene is also proposed as a candidate gene for involvement in limb anomalies, which was not observed in our cases.14 Although most features of JBS may be caused by deletion of different sets of contiguous genes, relative difference in the phenotypic expression may depend on the genetic background and gene–gene interactions in individual patient. The absence of typical JBS features in our patients may exclude an impact of genes in the deleted region on these features, but indicate a possible proximal localization of critical genes for JBS phenotype suggestive of a reduced penetrance. The overlap of phenotypic features between JBS and Noonan syndrome was not characteristically discernable in our patient other than a triangular facial appearance.15 The current study suggests that the detailed analysis is necessary in cases with milder phenotype. This can help to understand the underlying genetic etiology in 11q deletion phenotypes.
Table 1

Comparison of clinical features observed.

CLINICAL FEATURES IN JBSREPORTED PHENOTYPECASE 1CASE 2
Pregnancy and related complicationsIntrauterine growth retardation+
First signs and symptomsIntellectual disability++
Age at diagnosis4 years6½ years
Musculoskeletal problemsHypotonia++
Macrocrania
Facial asymmetry++
Microcephaly++
Brachycephaly (flat occiput)++
High prominent forehead++
Trigonocephaly
Ophthalmic problemsSparse eyebrows++
Hypertelorism++
Down slanting palpebral fissures+
Cataract
Strabismus++
Epicanthal folds++
Palpebral ptosis++
Nasal problemsShort nose
Flat nasal bridge++
Prominent nasal bridge++
Anteverted nares
Choanal atresia+
Flat alae nasi+
Prominent columella
Broad nasal bridge
Oral problemsSmooth and long philtrum++
Thick lower lip
V-shaped mouth++
High arched palate++
Retrognathia+
Problems with earSmall Low set ears++
Posteriorly rotated ears
Malformed external ears
Neck problemsShort and broad neck++
Neck webbing++
Anomalies of upper limbsThin fingers
Hypoplastic hypothenar region
Abnormal palmar creases
Cardiac anomaliesCardiac involvement (VSD)+
Anomalies of lower limbsClynodactylous toes++
Cutaneous syndactyly+
Stubby and flat feet
Large and long first toe
Brachydactyly
Hematological abnormalitiesThrombo-/Pancytopenia
  15 in total

1.  Diagnosis and fine mapping of a deletion in distal 11q in two Chinese patients with developmental delay.

Authors:  Taoyun Ji; Ye Wu; Huifang Wang; Jingmin Wang; Yuwu Jiang
Journal:  J Hum Genet       Date:  2010-06-03       Impact factor: 3.172

2.  Periventricular nodular heterotopia and transverse limb reduction defect in a woman with interstitial 11q24 deletion in the Jacobsen syndrome region.

Authors:  Joyce So; Tracy Stockley; Dimitri J Stavropoulos
Journal:  Am J Med Genet A       Date:  2013-12-05       Impact factor: 2.802

3.  Paris-Trousseau syndrome : clinical, hematological, molecular data of ten new cases.

Authors:  Remi Favier; Katayoun Jondeau; Patrice Boutard; Paul Grossfeld; Philippe Reinert; Christopher Jones; Francesco Bertoni; Elisabeth M Cramer
Journal:  Thromb Haemost       Date:  2003-11       Impact factor: 5.249

Review 4.  Interstitial 11q deletion derived from a maternal ins(4;11)(p14;q24.2q25): a patient report and review.

Authors:  Laura J C M Van Zutven; Yolande van Bever; Carolien C M Van Nieuwland; Gido C M Huijbregts; Diane Van Opstal; Anne R M von Bergh; Linda J A Corel; Dick Tibboel; Cokkie H Wouters; Pino J Poddighe
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

5.  Submicroscopic subtelomeric aberrations in Chinese patients with unexplained developmental delay/mental retardation.

Authors:  Ye Wu; Taoyun Ji; Jingmin Wang; Jing Xiao; Huifang Wang; Jie Li; Zhijie Gao; Yanling Yang; Bin Cai; Liwen Wang; Zhongshu Zhou; Lili Tian; Xiaozhu Wang; Nan Zhong; Jiong Qin; Xiru Wu; Yuwu Jiang
Journal:  BMC Med Genet       Date:  2010-05-11       Impact factor: 2.103

6.  Interstitial deletion of 11q-implicating the KIRREL3 gene in the neurocognitive delay associated with Jacobsen syndrome.

Authors:  Andrea Guerin; Dimitri J Stavropoulos; Yaser Diab; Sébastien Chénier; Hilary Christensen; Walter H A Kahr; Riyana Babul-Hirji; David Chitayat
Journal:  Am J Med Genet A       Date:  2012-09-10       Impact factor: 2.802

7.  The 11q terminal deletion disorder: a prospective study of 110 cases.

Authors:  Paul D Grossfeld; Teresa Mattina; Zona Lai; Remi Favier; Ken Lyons Jones; Finbarr Cotter; Christopher Jones
Journal:  Am J Med Genet A       Date:  2004-08-15       Impact factor: 2.802

8.  Clinical and molecular characterization of patients with distal 11q deletions.

Authors:  L A Penny; M Dell'Aquila; M C Jones; J Bergoffen; C Cunniff; J P Fryns; E Grace; J M Graham; B Kousseff; T Mattina
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

9.  Narrowing the critical region within 11q24-qter for hypoplastic left heart and identification of a candidate gene, JAM3, expressed during cardiogenesis.

Authors:  Helen M Phillips; Glenn L Renforth; Cosma Spalluto; Tom Hearn; Andrew R J Curtis; Lyndsey Craven; Beatrice Havarani; Mark Clement-Jones; Carol English; Oliver Stumper; Tony Salmon; Susie Hutchinson; Mike S Jackson; David I Wilson
Journal:  Genomics       Date:  2002-04       Impact factor: 5.736

10.  Submicroscopic deletions of 11q24-25 in individuals without Jacobsen syndrome: re-examination of the critical region by high-resolution array-CGH.

Authors:  Christine Tyson; Ying Qiao; Chansonette Harvard; Xudong Liu; Francois P Bernier; Barbara McGillivray; Sandra A Farrell; Laura Arbour; Albert E Chudley; Lorne Clarke; William Gibson; Sarah Dyack; Ross McLeod; Teresa Costa; Margot I Vanallen; Siu-Li Yong; Gail E Graham; Patrick Macleod; Millan S Patel; Jane Hurlburt; Jeanette Ja Holden; Suzanne Me Lewis; Evica Rajcan-Separovic
Journal:  Mol Cytogenet       Date:  2008-11-11       Impact factor: 2.009

View more
  4 in total

1.  Complex Mosaic Ring Chromosome 11 Associated with Hemizygous Loss of 8.6 Mb of 11q24.2qter in Atypical Jacobsen Syndrome.

Authors:  Alexandra Galvão Gomes; Carlos H Paiva Grangeiro; Luiz R Silva; Flávia G Oliveira-Gennaro; Ciro S Pereira; Tatiana M Joaquim; Rodrigo A Panepucci; Jeremy A Squire; Lucia Martelli
Journal:  Mol Syndromol       Date:  2016-11-17

2.  Immune Deficiency in Jacobsen Syndrome: Molecular and Phenotypic Characterization.

Authors:  Raquel Rodríguez-López; Fátima Gimeno-Ferrer; Elena Montesinos; Irene Ferrer-Bolufer; Carola Guzmán Luján; David Albuquerque; Carolina Monzó Cataluña; Virginia Ballesteros; Monserrat Aleu Pérez-Gramunt
Journal:  Genes (Basel)       Date:  2021-07-31       Impact factor: 4.096

3.  Jacobsen Syndrome: Surgical Complications due to Unsuspected Diagnosis, the Importance of Molecular Studies in Patients with Craniosynostosis.

Authors:  Etzalli P Linares Chávez; Jaime Toral López; Juan M Valdés Miranda; Luz M González Huerta; Adrian Perez Cabrera; María Del Refugio Rivera Vega; Olga M Messina Baas; Sergio A Cuevas-Covarrubias
Journal:  Mol Syndromol       Date:  2015-12-18

4.  Jacobsen syndrome and neonatal bleeding: report on two unrelated patients.

Authors:  Gregorio Serra; Luigi Memo; Vincenzo Antona; Giovanni Corsello; Valentina Favero; Paola Lago; Mario Giuffrè
Journal:  Ital J Pediatr       Date:  2021-07-01       Impact factor: 2.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.